Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Stream Ioannis Tarnanas: Atlantic Equity for Equity in Brain Health by Atlantic Fellows | Listen online for free on SoundCloud
Ioannis Tarnanas - Worldwebforum
Loop | Ioannis Tarnanas
Ioannis Tarnanas - Worldwebforum
PDF) Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study
Ioannis Tarnanas - Worldwebforum
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch
Ιωάννης Ταρνανάς | Cretalive
Ioannis Tarnanas (@ITarnanas) / Twitter
Altoida Raises $6.3 Million for Early, AI-Test for Alzheimer's Disease
EIT Health - Ioannis Tarnanas is the winner of #EIT Innovators Award. He is CSO for Altoida- makers of ADPS, which can tell if someone will develop Alzheimer's disease within 6 years,
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Cognitive Health & Digital Biomarker Technologies | Altoida
Handbook of Research on Innovations in the Diagnosis and Treatment of Dementia: 9781466682344: Medicine & Health Science Books @ Amazon.com
TGL2019 - Dr. Ioannis Tarnanas - YouTube
EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the
Ioannis Tarnanas | Nature Portfolio Health Community
Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
